You searched for "modelling"

1131 results found

NHS leaders must support doctors to act on new GMC guidance to challenge concerning behaviour at work

Dr John Holden responds to the publication of the revised Good Medical Practice (GMP) guidance from the General Medical Council.

Ophthalmology in the Middle East: Reflections from two electives in Jordan and the UAE

In the summer of 2021, I was fortunate enough to embark on two electives in ophthalmology at the Shami Eye Centre in Amman, Jordan, and Moorfields Eye Hospital in Dubai, United Arab Emirates (UAE). These eye hospitals serve distinct populations,...

Impact of Eye Health Surveys and Partnerships in The Gambia

This article brings together the three national eye health surveys that have been undertaken in The Gambia between 1986 and 2019 and the impact that the results have had nationally and internationally. In it we describe the long-term capacity-strengthening for...

Clinical relevance of the anatomic classification of neovascular age-related macular degeneration

The author explains why an OCT-based classification of neovascular AMD is needed and how these neovascular subtypes may help to predict patients’ long-term visual outcome. Age-related macular degeneration (AMD) is a chronic and progressive neurodegenerative process involving the macula in...

UKISOP 2023

by Lorcan Butler, Optical Engagement Manager, thebraintumourcharity.org, UKISCRS is the UK & Ireland Society of Cataract & Refractive Surgeons who had their annual Conference in London with a two-day event at The Leonardo City Hotel. On the other hand, UKISOP...

Verteporfin shortage: treatment options and outcomes in chronic non-resolving central serous chorioretinopathy

Half-dose photodynamic therapy (HD-PDT) with verteporfin has been the therapy of choice in non-resolving central serous chorioretinopathy lasting longer than four months. Since 2021, a worldwide shortage of verteporfin due to manufacturing issues prompted adjustments in treatment practices. This retrospective,...

Management of proliferative diabetic retinopathy

Diabetic retinopathy is a major cause of blindness in the working-age population. Due to the worsening global epidemic of diabetes, the incidence of morbidity caused by the disease is set to increase [1]. The prevalence of diabetes in the UK...

Friends of Moorfields shortlisted for the Charity Awards 2025

We are delighted to announce that we have made the shortlist for this year’s Charity Awards, the longest-running awards scheme in the charity sector. Friends of Moorfields has been shortlisted in the Healthcare and Medical Research category for our handholding...

Rite of passage

The Lakota Sioux people of Dakota have one of the best preserved Native American cultures in the United States and when people think of the ‘American Indian’ it is to the culture of the Lakota Sioux that people mostly turn....

The Wachter Review

Professor Robert Wachter (pronounced Wokter) is well known in the NHS IT sector. In late 2015 Jeremy Hunt announced he had tasked Dr Wachter to lead a review of the digital future of the NHS. The resulting Wachter Review was...

OXSIGHT Onyx – A sight-enhancing wearable

The Onyx is a newly-released (late 2021) wearable with a powered magnifier to assist those with central vision impairment. Unlike the previously covered wearable devices, this enhances existing sight. The unit can either be held against the eyes when needed,...

The College of Optometrists calls for shift in detecting and managing glaucoma

The College of Optometrists calls for shift in detecting and managing glaucoma by fully unlocking safe and effective primary care capacity Glaucoma is the second leading cause of irreversible sight loss in the UK and affects over one million people,...